Climb Bio, Inc.
CLYM • XNAS
Climb Bio, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Aoife Brennan BCh MMSc, with a market cap of $335.3M.
CEOAoife Brennan BCh MMSc
Next Earnings
Upcoming earnings announcement for Climb Bio, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.29
Earnings History
Past 12 earnings reports for Climb Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.26Est: -$0.20 | -30.0% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.19Est: -$0.15 | -26.7% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.13Est: -$0.19 | +31.6% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.31 | — | - | — | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.13 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.13 | — | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1.81 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.06 | — | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.13 | — | - | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$0.15 | — | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.19Est: -$0.16 | -18.8% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.84Est: -$0.25 | -236.0% | - | — | — |